• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对提高乳腺癌女性接受辅助内分泌治疗依从性的干预措施:对非依从性的可改变影响的基于理论的检查。

Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence.

机构信息

Data Science Centre, School of Population Heath Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Faculty of Kinesiology, University of New Brunswick, Fredericton, Canada.

出版信息

Support Care Cancer. 2023 Mar 4;31(3):200. doi: 10.1007/s00520-023-07658-x.

DOI:10.1007/s00520-023-07658-x
PMID:36869943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9985562/
Abstract

PURPOSE

To inform intervention development, we measured the modifiable determinants of endocrine therapy (ET) non-adherence in women with breast cancer, using the Theoretical Domains Framework (TDF) and examined inter-relationships between these determinants and non-adherence using the Perceptions and Practicalities Approach (PAPA).

METHODS

Women with stages I-III breast cancer prescribed ET were identified from the National Cancer Registry Ireland (N = 2423) and invited to complete a questionnaire. A theoretically based model of non-adherence was developed using PAPA to examine inter-relationships between the 14 TDF domains of behaviour change and self-reported non-adherence. Structural equation modelling (SEM) was used to test the model.

RESULTS

A total of 1606 women participated (response rate = 66%) of whom 395 (25%) were non-adherent. The final SEM with three mediating latent variables (LVs) (PAPA Perceptions: TDF domains, Beliefs about Capabilities, Beliefs about Consequences; PAPA Practicalities: TDF domain, Memory, Attention, Decision Processes and Environment) and four independent LVs (PAPA Perceptions: Illness intrusiveness; PAPA Practicalities: TDF domains, Knowledge, Behaviour Regulation; PAPA External Factors: TDF domain, Social Identity) explained 59% of the variance in non-adherence and had an acceptable fit (χ(334) = 1002, p < 0.001; RMSEA = 0.03; CFI = 0.96 and SRMR = 0.07) Knowledge had a significant mediating effect on non-adherence through Beliefs about Consequences and Beliefs about Capabilities. Illness intrusiveness had a significant mediating effect on non-adherence through Beliefs about Consequences. Beliefs about Consequences had a significant mediating effect on non-adherence through Memory, Attention, Decision Processesg and Environment.

CONCLUSIONS

By underpinning future interventions, this model has the potential to improve ET adherence and, hence, reduce recurrence and improve survival in breast cancer.

摘要

目的

为了指导干预措施的制定,我们使用理论领域框架(TDF)来衡量乳腺癌女性内分泌治疗(ET)不依从的可改变决定因素,并使用感知与实践方法(PAPA)来研究这些决定因素与不依从之间的相互关系。

方法

从爱尔兰国家癌症登记处(N = 2423)中确定了接受 ET 治疗的 I-III 期乳腺癌女性,并邀请她们完成一份问卷。使用 PAPA 来构建一个基于理论的不依从模型,以研究行为改变的 14 个 TDF 领域与自我报告的不依从之间的相互关系。结构方程模型(SEM)用于检验模型。

结果

共有 1606 名女性参与(应答率为 66%),其中 395 名(25%)不依从。最终的 SEM 模型包含三个中介潜在变量(PAPA 感知:TDF 领域、能力信念、后果信念;PAPA 实践:TDF 领域、记忆、注意力、决策过程和环境)和四个独立潜在变量(PAPA 感知:疾病侵扰;PAPA 实践:TDF 领域、知识、行为调节;PAPA 外部因素:TDF 领域、社会认同),解释了不依从的 59%,且具有可接受的拟合度(χ(334) = 1002,p < 0.001;RMSEA = 0.03;CFI = 0.96,SRMR = 0.07)。知识通过后果信念和能力信念对不依从有显著的中介作用。疾病侵扰通过后果信念对不依从有显著的中介作用。后果信念通过记忆、注意力、决策过程和环境对不依从有显著的中介作用。

结论

通过为未来的干预措施提供依据,该模型有可能提高 ET 依从性,从而降低乳腺癌的复发率并提高生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b1/9985562/b622ff6d05ef/520_2023_7658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b1/9985562/6c3aca2d2ab8/520_2023_7658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b1/9985562/b1631b7a6004/520_2023_7658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b1/9985562/b622ff6d05ef/520_2023_7658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b1/9985562/6c3aca2d2ab8/520_2023_7658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b1/9985562/b1631b7a6004/520_2023_7658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77b1/9985562/b622ff6d05ef/520_2023_7658_Fig3_HTML.jpg

相似文献

1
Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence.针对提高乳腺癌女性接受辅助内分泌治疗依从性的干预措施:对非依从性的可改变影响的基于理论的检查。
Support Care Cancer. 2023 Mar 4;31(3):200. doi: 10.1007/s00520-023-07658-x.
2
Women's experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour.乳腺癌激素治疗的女性经历:探究对服药行为的影响
Support Care Cancer. 2015 Nov;23(11):3115-30. doi: 10.1007/s00520-015-2685-x. Epub 2015 Mar 7.
3
Beliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancer.女性在接受乳腺癌辅助内分泌治疗时,其对癌症复发的恐惧与她们对药物和疾病的看法有关。
Br J Health Psychol. 2013 Feb;18(1):168-81. doi: 10.1111/bjhp.12003. Epub 2012 Nov 8.
4
Developing and validating a theoretical measure of modifiable influences on hormonal therapy medication taking behaviour in women with breast cancer.开发并验证一种针对乳腺癌女性激素治疗用药行为的可改变影响因素的理论测量方法。
Psychol Health. 2017 Oct;32(10):1308-1326. doi: 10.1080/08870446.2017.1296151. Epub 2017 Feb 28.
5
Mapping modifiable determinants of medication adherence in bipolar disorder (BD) to the theoretical domains framework (TDF): a systematic review.绘制双相情感障碍 (BD) 中可改变的药物依从性决定因素与理论领域框架 (TDF) 的关系:系统评价。
Psychol Med. 2021 May;51(7):1082-1098. doi: 10.1017/S0033291721001446. Epub 2021 May 19.
6
Identifying the determinants of adjuvant hormonal therapy medication taking behaviour in women with stages I-III breast cancer: A systematic review and meta-analysis.确定I-III期乳腺癌女性辅助激素治疗用药行为的决定因素:一项系统评价和荟萃分析。
Patient Educ Couns. 2015 May 30. doi: 10.1016/j.pec.2015.05.013.
7
Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach.辅助内分泌治疗乳腺癌患者药物依从性的促进因素和障碍:结构方程模型方法。
Breast Cancer Res Treat. 2021 Aug;188(3):779-788. doi: 10.1007/s10549-021-06204-9. Epub 2021 May 4.
8
What helps and hinders midwives in engaging with pregnant women about stopping smoking? A cross-sectional survey of perceived implementation difficulties among midwives in the North East of England.哪些因素有助于或阻碍助产士与孕妇就戒烟问题进行沟通?一项针对英格兰东北部助产士感知实施难点的横断面调查。
Implement Sci. 2012 Apr 24;7:36. doi: 10.1186/1748-5908-7-36.
9
Matching Adherence Interventions to Patient Determinants Using the Theoretical Domains Framework.使用理论领域框架将依从性干预措施与患者决定因素相匹配。
Front Pharmacol. 2016 Nov 14;7:429. doi: 10.3389/fphar.2016.00429. eCollection 2016.
10
Anesthesiologists' and surgeons' perceptions about routine pre-operative testing in low-risk patients: application of the Theoretical Domains Framework (TDF) to identify factors that influence physicians' decisions to order pre-operative tests.麻醉师和外科医生对低危患者常规术前检查的看法:应用理论领域框架(TDF)来确定影响医生术前检查决策的因素。
Implement Sci. 2012 Jun 9;7:52. doi: 10.1186/1748-5908-7-52.

引用本文的文献

1
Influencing Factors of Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients: A Meta-Analysis.乳腺癌患者辅助内分泌治疗依从性的影响因素:一项Meta分析
Health Sci Rep. 2025 Jun 18;8(6):e70934. doi: 10.1002/hsr2.70934. eCollection 2025 Jun.
2
Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life.开发 HT&Me 干预措施,以支持乳腺癌女性患者坚持辅助内分泌治疗并改善生活质量。
Breast. 2023 Aug;70:32-40. doi: 10.1016/j.breast.2023.05.007. Epub 2023 May 27.

本文引用的文献

1
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer.基于证据的方法用于管理乳腺癌辅助内分泌治疗的副作用。
Lancet Oncol. 2021 Jul;22(7):e303-e313. doi: 10.1016/S1470-2045(20)30666-5. Epub 2021 Apr 20.
2
Development of a self-management intervention to improve tamoxifen adherence in breast cancer survivors using an Intervention Mapping framework.使用干预映射框架开发一种自我管理干预措施,以提高乳腺癌幸存者对他莫昔芬的依从性。
Support Care Cancer. 2021 Jun;29(6):3329-3338. doi: 10.1007/s00520-020-05850-x. Epub 2020 Oct 29.
3
Women's coping strategies during the first three months of adjuvant endocrine therapy for breast cancer.
女性在乳腺癌辅助内分泌治疗的头三个月中的应对策略。
Nurs Open. 2019 Dec 13;7(2):605-612. doi: 10.1002/nop2.430. eCollection 2020 Mar.
4
Nonadherence to tamoxifen in breast cancer survivors: A 12 month longitudinal analysis.乳腺癌幸存者中他莫昔芬的不依从性:一项 12 个月的纵向分析。
Health Psychol. 2019 Oct;38(10):888-899. doi: 10.1037/hea0000785. Epub 2019 Jul 25.
5
Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain.辅助内分泌治疗依从性对无病生存和总生存的影响:西班牙加泰罗尼亚的一项基于人群的研究。
Breast Cancer Res Treat. 2019 Jun;175(3):733-740. doi: 10.1007/s10549-019-05201-3. Epub 2019 Mar 18.
6
Correspondence Between Objective and Self-reported Endocrine Therapy Adherence Among Women With Breast Cancer.乳腺癌女性患者客观和自我报告的内分泌治疗依从性之间的相关性。
Ann Behav Med. 2019 Aug 16;53(9):849-857. doi: 10.1093/abm/kay094.
7
Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer.开发一款电子健康应用程序,以支持乳腺癌治疗后接受辅助内分泌治疗的女性。
Patient Prefer Adherence. 2018 Dec 11;12:2639-2647. doi: 10.2147/PPA.S187692. eCollection 2018.
8
Interventions to promote adherence to endocrine therapy among breast cancer survivors: A meta-analysis.促进乳腺癌幸存者坚持内分泌治疗的干预措施:一项荟萃分析。
Psychooncology. 2019 Feb;28(2):255-263. doi: 10.1002/pon.4959. Epub 2018 Dec 28.
9
A systematic review of interventions to improve adherence to endocrine therapy.系统评价改善内分泌治疗依从性的干预措施。
Breast Cancer Res Treat. 2019 Feb;173(3):499-510. doi: 10.1007/s10549-018-5012-7. Epub 2018 Nov 1.
10
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.了解乳腺癌幸存者辅助内分泌治疗的持续情况。
BMC Cancer. 2018 Jul 11;18(1):732. doi: 10.1186/s12885-018-4644-7.